Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for accurate diagnostic testing
3.2.1.2 Advancements in diagnostic technologies
3.2.1.3 Rising demand for point-of-care testing
3.2.1.4 Stringent regulatory requirements
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of IVD quality control services
3.2.2.2 Limited reimbursement policies
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Regulatory landscape
3.6 Pricing analysis
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Quality control
5.2.1 Serum/plasma-based controls
5.2.2 Whole blood-based controls
5.2.3 Urine-based controls
5.2.4 Other quality controls
5.3 Data management solutions
5.3.1 Laboratory information management systems (LIMS)
5.3.2 Standalone software
5.4 Quality assurance services
Chapter 6 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Control
6.2.1 Total protein
6.2.2 Albumin
6.2.3 Blood urea nitrogen
6.2.4 Uric acid
6.2.5 Creatinine
6.2.6 Sodium
6.2.7 Potassium
6.2.8 Chloride
6.2.9 Calcium
6.2.10 Magnesium
6.2.11 Aspartate transaminase
6.2.12 Creatine kinase
6.2.13 Gamma glutamyl transferase
6.2.14 Total bilirubin
6.2.15 Other controls
6.3 Calibrators
6.4 Calibration verifiers
6.5 Other products
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Immunoassay
7.3 Clinical chemistry
7.3.1 Electrolytes and minerals
7.3.2 Renal function
7.3.3 Liver function
7.3.4 Proteins and enzymes
7.3.5 Cardiac markers
7.3.6 Other clinical chemistry applications
7.4 Molecular diagnostics
7.4.1 Nucleic acid amplification tests
7.4.2 DNA sequencing
7.4.3 Genetic testing
7.4.4 Other molecular diagnostic applications
7.5 Microbiology
7.6 Hematology
7.7 Coagulation and hemostasis
7.8 Other applications
Chapter 8 Market Estimates and Forecast, By Manufacturer Type, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Third party controls
8.2.1 Independent controls
8.2.2 Instrument specific controls
8.3 Original equipment manufacturer controls
Chapter 9 Market Estimates and Forecast, By End Use , 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Hospitals
9.3 Clinical laboratories
9.4 Academic and research institutes
9.5 Other end users
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
Chapter 11 Company Profiles
11.1 Abbott
11.2 Agilent Technologies
11.3 Becton, Dickinson and Company
11.4 Bio-Rad Laboratories
11.5 Bio-Techne Corporation
11.6 Danaher Corporation
11.7 F. Hoffmann-La Roche
11.8 Helena Laboratories Corporation
11.9 Hologic
11.10 Merck
11.11 QIAGEN
11.12 QuidelOrtho Corporation
11.13 Randox Laboratories
11.14 Siemens Healthineers
11.15 Sysmex Corporation
11.16 Technopath Manufacturing
11.17 Thermo Fisher Scientific
